The declaration voiced support for a global plan set out by the World Health Organisation (WHO) and World Animal Health Organization (OIE) to reduce inappropriate use of antibiotics in humans and animals.
On January 21, 2016, the Declaration by the Pharmaceutical, Biotechnology and Diagnostics Industries on Combating Antimicrobial Resistance was launched at the World Economic Forum in Davos, Switzerland.
Olmix Group joined the campaign among other 85 companies and 9 associations from the global pharmaceutical, diagnostics and biotechnology industries in 18 different countries. In addition to manufacturers, 8 industry associations signed the declaration, including the BEAM alliance (Biotechnology companies from Europe innovating in Anti-Microbial resistance research), in wich Olmix Group participates.
The declaration voiced support for a global plan set out by the World Health Organisation (WHO) and World Animal Health Organization (OIE) to reduce inappropriate use of antibiotics in humans and animals. Excessive use of antibiotics accelerates the rise of superbugs by giving bacteria more opportunities to build resistance.
Furthermore, they also called on governments to support new commercial models that would increase incentives for research and development while discouraging overuse of the resulting drugs, including in livestock industry.
To this end, signatories give strong support to "One Health approach towards prudent and responsible use, including a global phased reduction of unnecessary antibiotic use in livestock, and they applaud moves from major food groups to work towards this goal".
Olmix Group, developing the "One Health, Thanks to Algae" program, is committed to contributing to this global public health challenge by providing agriculture, livestock and food industry with algae-based natural solutions, for a better life.